Atlas Trials

Preoperative Folfirinox for Resectable Pancreatic Adenocarcinoma - A Phase II Study

Clinical trial NCT02345460 · TERMINATED

Trial details

NCT number
NCT02345460
Sponsor
Case Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic AdenocarcinomaPoorly Differentiated Malignant NeoplasmResectable Pancreatic CancerStage IA Pancreatic CancerStage IB Pancreatic CancerStage IIA Pancreatic CancerStage IIB Pancreatic CancerStage III Pancreatic CancerUndifferentiated Pancreatic Carcinoma
Start date
2015-09-01
Primary completion
2016-02-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.